Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZW) Cash & Current Investments (2021 - 2025)

Core Scientific (CORZW) has disclosed Cash & Current Investments for 5 consecutive years, with $311.4 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments fell 62.8% to $311.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $311.4 million through Dec 2025, down 62.8% year-over-year, with the annual reading at $311.4 million for FY2025, 62.8% down from the prior year.
  • Cash & Current Investments hit $311.4 million in Q4 2025 for Core Scientific, down from $453.4 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $837.0 million in Q4 2024 to a low of $1.6 million in Q3 2021.
  • Historically, Cash & Current Investments has averaged $212.9 million across 5 years, with a median of $103.8 million in 2022.
  • Biggest five-year swings in Cash & Current Investments: soared 14290.56% in 2022 and later crashed 73.91% in 2023.
  • Year by year, Cash & Current Investments stood at $131.7 million in 2021, then crashed by 60.33% to $52.2 million in 2022, then surged by 33.44% to $69.7 million in 2023, then surged by 1100.68% to $837.0 million in 2024, then crashed by 62.8% to $311.4 million in 2025.
  • Business Quant data shows Cash & Current Investments for CORZW at $311.4 million in Q4 2025, $453.4 million in Q3 2025, and $581.3 million in Q2 2025.